Benjamin J. Hindson serves as Executive at 10x Genomics, Inc., where they oversee executive responsibilities. Since joining the company, Benjamin J. Hindson has executed 211 insider transactions totaling $124.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 1, 2020 involved selling 13,207 shares valued at $770.9K.
Benjamin J. Hindson currently holds 424,779 shares of 10x Genomics, Inc. (TXG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benjamin J. Hindson has been a net seller of TXG stock. They have purchased $0 and sold $124.6M worth of shares.
Benjamin J. Hindson's most recent insider trade was on Apr 1, 2020, when they sold 13,207 shares at $58.37 per share.
Get notified when new Form 4 filings are submitted
| $67.96 |
| Discretionary |
| Mar 6, 2020 | TXG | $29.7K | Option Exercise | 33,750 | $0.88 | Discretionary |
| Mar 6, 2020 | TXG | $268.5K | Sale | 3,845 | $69.84 | Discretionary |
| Mar 6, 2020 | TXG | $214.5K | Sale | 3,099 | $69.20 | Discretionary |
| Mar 6, 2020 | TXG | $301.1K | Sale | 4,788 | $62.88 | Discretionary |
| Mar 6, 2020 | TXG | $133.5K | Sale | 2,000 | $66.73 | Discretionary |
| Mar 6, 2020 | TXG | $250.9K | Sale | 3,816 | $65.74 | Discretionary |
| Mar 6, 2020 | TXG | $402.1K | Sale | 6,200 | $64.85 | Discretionary |
| Mar 6, 2020 | TXG | $555.0K | Sale | 8,702 | $63.78 | Discretionary |
| Jan 3, 2020 | TXG | $59.4K | Option Exercise | 67,500 | $0.88 | Discretionary |